Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 6.25166 | 85 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.0964 | 83 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.33692 | 85 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.59833 | 85 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.99861 | 82 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.96986 | 84 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 6.05686 | 84 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 6.19466 | 84 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.38724 | 85 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.26125 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.22401 | 84 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.21932 | 84 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.34796 | 85 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.22053 | 84 |